SB-258719

SB-258719
SB-258719
SB-258719 structure.png
식별자
  • (1R)-3,N-디메틸-N-[1-메틸-3-(4-메틸피페리딘-1-yl)프로필]벤젠설폰아미드
CAS 번호
펍켐 CID
IUPHAR/BPS
켐스파이더
켐벨
화학 및 물리적 데이터
공식C18H32N2O2S
어금질량340.53 g·190−1
3D 모델(JSmol)
  • c1cc(C)cc1S(=O)N(C)CCN(CC2)CC2C
  • InChI=1S/C18H30N2O2S/c1-15-8-11-20(12-9-15)13-10-17(3)19(4)23(21,22)18-7-5-6-16(2)14-18/h5-7,14-15,17H,8-13H2,1-4H3/t17-/m1/s1 checkY
  • 키:AGVNHDNTFYHzN-QGZVFFLSA-N checkY
☒NcheckY (이게 뭐야?) (iii)

SB-258719GlaxoSmithKline7 개발한 약물로 선택적 5-HT 수용체 부분 역작용제 역할을 하며,[1] 5-HT에서7 확인된 리간드로는 최초다.[2] SB-258719는 여러 가지 다른 시험 모델에 걸쳐 다양한 5-HT7 작용제의 진통 효과를 차단하는 능력 때문에 주로 5-HT7 작용제의 잠재적 진통제 사용 가능성을 입증하는 데 사용되어 왔다.[3][4][5][6]

참조

  1. ^ Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P (July 2004). "Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors". European Journal of Pharmacology. 495 (2–3): 97–102. doi:10.1016/j.ejphar.2004.05.033. PMID 15249157.
  2. ^ Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, et al. (February 1998). "(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist". Journal of Medicinal Chemistry. 41 (5): 655–7. doi:10.1021/jm970519e. PMID 9513592.
  3. ^ Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A, et al. (February 2009). "5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice". Pain. 141 (3): 239–47. doi:10.1016/j.pain.2008.11.009. PMID 19118950.
  4. ^ Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, et al. (March 2010). "Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways". Anesthesiology. 112 (3): 696–710. doi:10.1097/ALN.0b013e3181cd7920. PMID 20179508.
  5. ^ Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, et al. (June 2010). "Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity". Pain. 149 (3): 483–94. doi:10.1016/j.pain.2010.03.007. PMID 20399562.
  6. ^ Brenchat A, Ejarque M, Zamanillo D, Vela JM, Romero L (August 2011). "Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors". Journal of Pharmacological Sciences. 116 (4): 388–91. doi:10.1254/jphs.11039sc. PMID 21778664.